Business

January 3, 2014 1:26 PM

FDA cites Dara BioSciences for misleading marketing of Soltamox

Federal regulators have cited Raleigh-based Dara BioSciences for running misleading sales aids for Soltamox, an oral liquid formulation used in the treatment and prevention of breast cancer.

Related content

Suggested for you

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos